| Dawn Marie Burke, ANP-BC | |
|
13914 Southeastern Pkwy Ste 108, Fishers, IN 46037-7127 | |
| (317) 415-9110 | |
| Not Available |
| Full Name | Dawn Marie Burke |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 15 Years |
| Location | 13914 Southeastern Pkwy Ste 108, Fishers, Indiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093049819 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LA2200X | Nurse Practitioner - Adult Health | 71003040A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ascension St Vincent Fishers | Fishers, IN | Hospital |
| Indiana University Health | Indianapolis, IN | Hospital |
| Ascension St Vincent Hospital | Indianapolis, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Vincent Medical Group Inc | 7012047640 | 625 |
News Archive
Non-Hispanic Black patients with non-small cell lung cancer (NSCLC) who were treated with immunotherapy had a lower risk of death than their non-Hispanic white counterparts treated with immunotherapy, according to results presented at the virtual 14th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, held October 6-8, 2021.
Hemispherx Biopharma, Inc., announced that the Company executed an exclusive revenue sharing Sales, Marketing, Distribution and Supply Agreement for Argentina with GP Pharm Latinoamerica, an affiliate company of Spanish GP Pharm SA.
IRIN examines a Health Affairs report that found "one in four families living in the world's poorest countries borrows money or sells assets in order to afford health care" (7/15).
Lexicon Pharmaceuticals, Inc. will present six posters summarizing the mechanism of action and safety of LX4211, a dual inhibitor of sodium glucose transporters 1 and 2 (SGLT1 and SGLT2) currently in mid-stage development for type 2 diabetes, at the 72nd Scientific Sessions of the American Diabetes Association (ADA) in Philadelphia, Pennsylvania during the Saturday morning poster session on June 9, 2012.
One-year data from the PARTNER clinical trial, published today in the New England Journal of Medicine, demonstrate that transcatheter aortic-valve implantation, compared with standard therapy, resulted in significantly lower rates of death among patients who cannot undergo surgery for aortic stenosis. The results will be presented tomorrow as a Late Breaking Trial at the 22nd annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium.
› Verified 3 days ago
| Entity Name | St Vincent Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144513375 PECOS PAC ID: 7012047640 Enrollment ID: O20100609000045 |
News Archive
Non-Hispanic Black patients with non-small cell lung cancer (NSCLC) who were treated with immunotherapy had a lower risk of death than their non-Hispanic white counterparts treated with immunotherapy, according to results presented at the virtual 14th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, held October 6-8, 2021.
Hemispherx Biopharma, Inc., announced that the Company executed an exclusive revenue sharing Sales, Marketing, Distribution and Supply Agreement for Argentina with GP Pharm Latinoamerica, an affiliate company of Spanish GP Pharm SA.
IRIN examines a Health Affairs report that found "one in four families living in the world's poorest countries borrows money or sells assets in order to afford health care" (7/15).
Lexicon Pharmaceuticals, Inc. will present six posters summarizing the mechanism of action and safety of LX4211, a dual inhibitor of sodium glucose transporters 1 and 2 (SGLT1 and SGLT2) currently in mid-stage development for type 2 diabetes, at the 72nd Scientific Sessions of the American Diabetes Association (ADA) in Philadelphia, Pennsylvania during the Saturday morning poster session on June 9, 2012.
One-year data from the PARTNER clinical trial, published today in the New England Journal of Medicine, demonstrate that transcatheter aortic-valve implantation, compared with standard therapy, resulted in significantly lower rates of death among patients who cannot undergo surgery for aortic stenosis. The results will be presented tomorrow as a Late Breaking Trial at the 22nd annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dawn Marie Burke, ANP-BC 13914 Southeastern Pkwy Ste 108, Fishers, IN 46037-7124 Ph: () - | Dawn Marie Burke, ANP-BC 13914 Southeastern Pkwy Ste 108, Fishers, IN 46037-7127 Ph: (317) 415-9110 |
News Archive
Non-Hispanic Black patients with non-small cell lung cancer (NSCLC) who were treated with immunotherapy had a lower risk of death than their non-Hispanic white counterparts treated with immunotherapy, according to results presented at the virtual 14th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, held October 6-8, 2021.
Hemispherx Biopharma, Inc., announced that the Company executed an exclusive revenue sharing Sales, Marketing, Distribution and Supply Agreement for Argentina with GP Pharm Latinoamerica, an affiliate company of Spanish GP Pharm SA.
IRIN examines a Health Affairs report that found "one in four families living in the world's poorest countries borrows money or sells assets in order to afford health care" (7/15).
Lexicon Pharmaceuticals, Inc. will present six posters summarizing the mechanism of action and safety of LX4211, a dual inhibitor of sodium glucose transporters 1 and 2 (SGLT1 and SGLT2) currently in mid-stage development for type 2 diabetes, at the 72nd Scientific Sessions of the American Diabetes Association (ADA) in Philadelphia, Pennsylvania during the Saturday morning poster session on June 9, 2012.
One-year data from the PARTNER clinical trial, published today in the New England Journal of Medicine, demonstrate that transcatheter aortic-valve implantation, compared with standard therapy, resulted in significantly lower rates of death among patients who cannot undergo surgery for aortic stenosis. The results will be presented tomorrow as a Late Breaking Trial at the 22nd annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium.
› Verified 3 days ago
Mrs. Amanda Rebecca Lucke, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 11501 Cumberland Rd Ste 500, Fishers, IN 46037 Phone: 317-863-9300 Fax: 317-863-9333 | |
Heather Hosfield, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 13121 Olio Rd, #100, Fishers, IN 46037 Phone: 317-621-4044 Fax: 317-621-4050 | |
Deborah L Schutz, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 8890 E 116th St, Suite 300, Fishers, IN 46038 Phone: 317-621-1500 Fax: 317-621-1509 | |
Courtney Joy Young, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 9795 E 116th St, Fishers, IN 46037 Phone: 317-913-8100 | |
Nieasha Lanise Richardson, APN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 9894 E 121st St, Fishers, IN 46037 Phone: 317-621-2273 Fax: 317-806-1653 | |
Amy Woebkenberg, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 13121 Olio Rd Ste 300, Fishers, IN 46037 Phone: 317-621-1300 Fax: 317-621-1310 | |
Melissa Carter, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 10546 Greenway Dr, Fishers, IN 46037 Phone: 317-437-7453 |